INTRODUCTION
============

To date, the management of concomitant gallbladder and common bile duct (CBD) stones is still controversial. There are several approaches to the treatment of biliary lithiasis, including laparoscopic common bile duct exploration (LCBDE) and pre-, intra-, or postoperative endoscopic retrograde cholangiopancreatography (ERCP). Despite these multiple options and the improvement of minimally invasive techniques, many surgeons still perform an open CBD exploration with external biliary drainage (EBD).

The simultaneous laparoscopic treatment of CBD stones during laparoscopic cholecystectomy (LC) has demonstrated advantages when compared with other surgical approaches.^[@B1][@B2][@B3]^ However, the laparoscopic exploration of the bile ducts requires the proper equipment as well as expertise in advanced surgical skills, such as bile duct suturing and stones extraction. The removal of biliary stones can be achieved either through the cystic duct or by choledochotomy. Although both approaches are useful and have precise indications, the transcholedochal route has been associated with a higher morbidity rate, mainly related to the frequent use of a T-tube for biliary decompression.^[@B4]^ Regarding this particular issue, the use of a transpapillary stent (TS) appears to be a valuable and safe alternative to avoid these complications with satisfactory outcomes.^[@B5]^

The aim of this study was to analyze the morbidity, mortality, and outcomes between patients with biliary lithiasis who underwent LCBDE and biliary stenting versus external biliary drainage.

METHODS
=======

The current report presents a single-institution retrospective analysis of a prospectively maintained database. Between January 2007 and May 2012, a total of 3700 consecutive patients underwent an LC to treat gallbladder lithiasis at the Hospital Italiano de Buenos Aires. In 356 (9.6%) patients, choledocholithiasis was diagnosed or confirmed by routine intraoperative cholangiography (IOC) and were treated by an LCBDE. In all of these patients, stone extraction was attempted, either transcystically or with transcholedochal exploration. In 48 (13%) patients, either TS or EBD was required for biliary decompression as a result of residual stones or reduced flow of contrast material into the duodenal lumen. This group was included is this study analysis.

Surgical Technique
------------------

The American technique of LC was used with the patient in the prone position. Four trocars were used (one 10-mm umbilical, one 5-mm epigastric, two 5-mm in the right flank). IOC was routinely used and performed through a cholangiography catheter into the cystic duct. Once the presence of biliary stones was confirmed, LCBDE under fluoroscopic control was performed with the use of a Web--2×4 extraction basket (Cook Medical, Bloomington, Indiana) either through the cystic duct or by choledochotomy. The presence of multiple or intrahepatic stones and low cystic duct--CBD junction were indications to perform a choledochotomy.

For biliary decompression either TS or EBD was considered depending on the operating surgeon\'s experience, the availability of the material, the possibility of cannulating the ampulla with a wire guide, and the presence of residual stones. For transpapillary stenting, a 7-Fr plastic biliary stent was placed (Cotton-Leung 7--9, Cook Medical) (**[Figure 1](#F1){ref-type="fig"}**). If a choledochotomy had been performed, primary biliary closure consisted of interrupted 5-0 polydioxanone stitches (PDS II, Ethicon, Somerville, New Jersey) with the intracorporeal knot-suturing technique. For EBD, a T-tube was placed using the same surgical technique as the open approach. At the end of the procedure, an IOC was performed to certify a proper repair, ensure an appropriate positioning of the stent or the T-tube, and confirm the free flow of contrast into the duodenum (**[Figure 2](#F2){ref-type="fig"}**). Once a proper biliary decompression was certified, an LC was performed.

![LCBDE and TS placement using the transcystic approach.](jls0011432780001){#F1}

![IOC showing the correct placement of the TS.](jls0011432780002){#F2}

### Follow-Up.

During patients\' hospital stay, daily clinical evaluation and laboratory tests were performed. After discharge, the patients were controlled every 3 months during the first year and annually thereafter (with clinical evaluation and liver function tests done). According to the findings, additional imaging studies were used to rule out biliary stenosis. The Dindo-Clavien classification^[@B6]^ was used to stratify the severity of complications.

Statistical Analysis
--------------------

For comparison between treatment modality, the χ^2^ test was used for categorical variables and the Student *t* test was used for continuous variables. Analyses were performed using NCSS software (version 2007, NCSS Kaysville, Utah). All statistical tests were two-sided and statistical significance was defined as *P*\<.05.

RESULTS
=======

Of the 48 patients who comprised the study population, all underwent an LCBDE without conversion to open surgery. The successful clearance of stones was achieved in 41 (85%) patients.

Eighteen patients (37%) underwent a transcystic stone extraction, and 30 patients (63%) required a choledochotomy. TS and EBD were placed in 35 (73%) and 13 (27%) patients, respectively (**[Figure 3](#F3){ref-type="fig"}**).
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Data analyzed were compared between both groups (TS vs EBD). There were no statistically significant differences in epidemiological characteristics and preoperative factors (**[Table 1](#T1){ref-type="table"}**). Regarding operative times, there were no statistically significant differences between both groups (*P*=0.08). However, postoperative complications were significantly higher (*P*\<.0001) in the group with an EBD (**[Table 2](#T2){ref-type="table"}**). Overall morbidity in the EBD group was 38% (5 patients), with two patients developing acute pancreatitis, two developing cholangitis, and 1 presenting with an accidental displacement of the T-tube. Regarding the TS group, one patient presented with a biliary peritonitis in the immediate postoperative period that required reoperation. During laparoscopic exploration, an accessory duct of Luschka was diagnosed and sutured, and the patient had a favorable recovery. There were no intra- or postoperative deaths. Regarding hospital stay, the TS group presented a faster recovery than the EBD group (**[Table 3](#T3){ref-type="table"}**). This difference was also statistically significant (*P*=.03).

###### 

Epidemiological Characteristics: Preoperative Factors

                    Transpapillary Stent, n (%)   External drainage, n (%)   *P* value
  ----------------- ----------------------------- -------------------------- -----------
  Age (y)           60.2 (33--83)                 64.1 (28--88)              .56
  M/F (sex ratio)   2:1                           1:1                        NS
  Consult                                                                    
      Pain          35 (100)                      12 (92)                    NS
      Jaundice      26 (80)                       3 (23)                     NS
      Fever         9 (25)                        4 (30)                     NS
      Dyspepsia     5 (14)                        2 (15)                     NS

NS, not significant.

###### 

Postoperative Complications

                                          Transpapillary Stent, n (%)   External drainage, n (%)   *P* value
  --------------------------------------- ----------------------------- -------------------------- -----------
  Morbidity                               1 (2.8)                       5 (38)                     .0001
  Mortality                               0                             0                          
  Type of complications (DC)                                                                       
      Choleperitoneum (IVa)               1 (2.8)                       0                          .53
      Pancreatitis (II)                   0                             2 (15)                     .02
      Cholangitis (II)                    0                             2 (15)                     .02
      Accidental tube displacement (II)   0                             1                          .1

###### 

Media Time of Surgery, Hospital Stay, and Removal of Stent or Drainage

                                     Transpapillary Stent, n (%)   External Drainage, n (%)   *P* value
  ---------------------------------- ----------------------------- -------------------------- -----------
  Surgery time (min)                 150 (90--210)                 183 (130--250)             .08
  Hospital stay (d)                  3 (2--6)                      6 (4--10)                  .03
  Removal of stent or drainage (d)   30 (15--90)                   45 (30--70)                .08

Those patients in the TS group underwent a postoperative outpatient ERCP for stent removal on average 4 weeks (range, 15--90 days) after surgery, with successful cannulation and stent removal in all cases. None of these patients presented with ERCP-related complications. In addition, 7 patients (20%) in this group presented with residual biliary lithiasis that was successfully treated during the same endoscopy. In patients with an EBD, a transcatheter cholangiography was performed 6 weeks (range, 30--70 days) after surgery, which showed free contrast flow into the duodenum lumen without residual lithiasis in all patients, thus the drain was removed.

DISCUSSION
==========

Today, LC has become the gold standard treatment for gallstone disease. Approximately 8% to 15% of the patients with symptomatic gallstones have simultaneous choledocholithiasis.^[@B4]^ Historically, in patients with a preoperative diagnosis of CBD stones during the early laparoscopic era, a two-stage surgical approach (ERCP followed by LC) was the preferred treatment for most surgeons.^[@B7][@B8][@B9]^ However, this approach presented several disadvantages. CBD stones often escape notice in ordinary preoperative work-up for LC such as with liver function tests or ultrasonography, making preoperative diagnosis challenging.^[@B7],[@B10]^ Alternatively, ERCP has been associated with a morbidity of 7% to 15%^[@B11][@B12][@B13]^ and a cannulation failure rate ranging from 5% to 20%.^[@B11]^

Recent studies have demonstrated the advantages of the laparoscopic treatment of CBD stones in a single stage, with equivalent results to those of ERCP.^[@B12]^ Moreover, the increasing adoption of IOC has brought the laparoscopic surgeon against the potential situation of having to deal with the presence of unsuspected choledocholithiasis. Currently, LCBDE and stone extraction have become safe and valuable alternatives in the hands of skilled surgeons---either transcystically or through a choledochotomy.^[@B5]^ Because of a lower complication rate,^[@B14][@B15][@B16]^ laparoscopic exploration through the cystic duct remains the access location of choice.^[@B13],[@B17],[@B18]^ However, a low cystic duct--CBD junction and large (≥10 mm), multiple, or intrahepatic stones are indications to perform a choledochotomy.^[@B19]^ In 18 (37%) patients in our series, the CBD exploration was achieved through the cystic duct, and 30 (63%) patients underwent a choledochotomy. An EBD was used for biliary decompression in less than half of the patients who had a choledochotomy performed.

EBD was a safe and effective method to prevent biliary leakage or to provide an effective biliary decompression in cases of incomplete stone removal after choledochotomy closure in the open cholecystectomy era. Despite these advantages, T-tube--related complications were discussed for decades, with 15% to 28% morbidity either in the open or laparoscopic approach.^[@B20],[@B21]^ The most common complications described are postoperative cholangitis, accidental T-tube displacement, and biliary leakage after drainage removal.^[@B21],[@B22]^ Recent literature suggests that laparoscopic endobiliary stents decrease postoperative T-tube--related complications, improving patient comfort and a promoting a faster recovery.^[@B19],[@B23][@B24][@B25]^ In our series, the stent group had significantly fewer complications than the EBD group (2.8% vs 38%), which is consistent with the current literature. In addition, those patients in the EBD group had two times longer hospital stays than those in the TS group, with discharges 3 and 6 days after surgery, respectively.

The main drawback of placing a TS after LCBDE is the need for a second procedure (ERCP) to remove the stent. In our series, ERCP was successfully performed in all patients in whom a transpapillary stent was placed, with the removal of the stent and stones extraction as a frequent associated procedure. In this particular regard, the success rate of stone clearance after LCBDE was 85%, which is similar to that of other authors.^[@B26]^ The presence of residual stones is an additional reason that justifies a postoperative ERCP. The absence of cannulation failure in the ERCP, an event that has been reported in as many as 20% of patients with CBD stones, is another advantage of the stenting group that should be taken into account to decide which strategy to use whenever biliary decompression is needed after CBDE.^[@B27]^

Despite the results and their statistical value, our study presents some weaknesses because it is a retrospective study in a single institution. Because of this, we emphasize the need for randomized controlled trials to clarify and support our findings.

CONCLUSION
==========

LCBDE remains a challenge even for skilled surgeons with laparoscopic training. However, the excellent results obtained make this approach a safe and useful tool to treat the CBD stones. The laparoscopic transpapillary stenting shows several advantages compared with external biliary drainage. It has lower morbidity and mortality rates, requires a shorter hospital stay, and gives the additional benefit of achieving a high rate of CBD cannulation and stone extraction with postoperative ERCP, thus avoiding repeat surgical or endoscopic procedures to treat residual lithiasis.
